Found: 41
Select item for more details and to access through your institution.
Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure.
- Published in:
- Cardiovascular Research, 2002, v. 55, n. 4, p. 710, doi. 10.1016/S0008-6363(02)00466-2
- By:
- Publication type:
- Article
Heart failure with preserved ejection fraction: treat now by treating comorbidities.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Monotherapy of stable angina with nicardipine hydrochloride: double-blind, placebo-controlled, randomized study.
- Published in:
- European Heart Journal, 1989, v. 10, n. 8, p. 695, doi. 10.1093/oxfordjournals.eurheartj.a059553
- By:
- Publication type:
- Article
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Vasopressin V1 receptor-mediated aldosterone production as a result of selective V2 receptor antagonism: a potential explanation for the failure of tolvaptan to reduce cardiovascular outcomes in the EVEREST trial.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: A comparison with natriuretic peptides
- Published in:
- European Journal of Heart Failure, 2008, v. 10, n. 1, p. 70, doi. 10.1016/j.ejheart.2007.10.009
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 1, p. 47, doi. 10.1038/sj.bmt.1705698
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 1, p. S29, doi. 10.1038/sj.bmt.1704177
- By:
- Publication type:
- Article
Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo- controlled, randomised, repeated cross-over study.
- Published in:
- British Journal of Clinical Pharmacology, 1985, v. 20, n. S1, p. 195S, doi. 10.1111/j.1365-2125.1985.tb05164.x
- By:
- Publication type:
- Article
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
- Published in:
- 2009
- By:
- Publication type:
- journal article
The disconnect between phase II and phase III trials of drugs for heart failure.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Prognostic value and changes in renal function in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
The early assessment of dyspnea in patients with acute heart failure syndromes - the Ularitide Global Evaluation in Acute Decompensated Heart Failure (URGENT) study
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Coronary angiography, subsequent use of medical therapy/revascularization, and survival in acute heart failure: a report from OPTIMIZE-HF
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Mode of death and cardiovascular re-hospitalization in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Prognostic value and changes in renal function in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
The early assessment of dyspnea in patients with acute heart failure syndromes - the Ularitide Global Evaluation in Acute Decompensated Heart Failure (URGENT) study
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Coronary angiography, subsequent use of medical therapy/revascularization, and survival in acute heart failure: a report from OPTIMIZE-HF
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Mode of death and cardiovascular re-hospitalization in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program
- Published in:
- 2008
- By:
- Publication type:
- Abstract
336 The prevalence of asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study
- Published in:
- 2007
- By:
- Publication type:
- Abstract
64 The role of NT-proBNP for detecting asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study
- Published in:
- 2007
- By:
- Publication type:
- Abstract
336 The prevalence of asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study
- Published in:
- 2007
- By:
- Publication type:
- Abstract
64 The role of NT-proBNP for detecting asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study
- Published in:
- 2007
- By:
- Publication type:
- Abstract
114 Anemia as a predictor of death and rehospitalization in patients with advanced decompensated heart failure: insights from the OPTIME-CHF study
- Published in:
- 2004
- By:
- Publication type:
- Abstract
455 Length of stay for heart failure hospitalization in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)
- Published in:
- 2004
- By:
- Publication type:
- Abstract